Skip to main content

News categories: Honors & Funding

Kerstin Ludwig: Professor at the University of Bonn

The Cluster of Excellence ImmunoSensation2 celebrates the appointment of Prof. Dr. Kerstin Ludwig to a W2 professorship at the University of Bonn.

The Cluster of Excellence ImmunoSensation2 celebrates the appointment of Prof. Dr. Kerstin Ludwig to the W2 professorship “Immune Genetics” at the University of Bonn. As leading expert in the field of complex trait genetics, Kerstin Ludwig’s work has advanced our understanding of genetic factors contributing to a number of multifactorial diseases, including infectious diseases.  

A Journey of Academic Excellence

Kerstin Ludwig has been deeply engaged in the field of human genetics since her early academic career. Her journey began with her international diploma studies in Germany, France and Canada, which sparked a lifelong passion for understanding how genetics influence human health and disease. Following this, she pursued her doctoral research on the genetic contributors to dyslexia, under the mentorship of Prof. Dr. Markus Nöthen at the University of Bonn. The experience of being part of a large European consortium at that time laid the ground for her deep appreciation of the value of joint collaborative work.  

During her postdoctoral years, Kerstin Ludwig extended her scientific portfolio to study the genetic factors underlying human facial disorders. She identified numerous risk factors for orofacial clefting, one of the most common birth defects, and established first NGS approaches at the Medical Faculty. This work was subsequently recognized through her admission to prestigious programs: She was supported by the BONFOR program, which nurtures promising early-career researchers at the University of Bonn, the Emmy Noether Program of the German Research Foundation (DFG), a highly selective initiative designed to foster scientific independence, and she became a selected member of the “Junges Kolleg” of the NRW Academy of Sciences and Arts.

With the beginning of the SARS-CoV-2 pandemic, Kerstin Ludwig applied her scientific and technological expertise in the emerging field of host genetics. She contributed to research on COVID-19 and established the BoSCO study, which aims at investigating the genetic factors influencing SARS-CoV-2 susceptibility, COVID-19 severity and long-term outcomes. She also was a co-leader of the DeCOI host genetics group, which aggregated genome sequencing data across different sites in Germany, and contributed to the development of a novel high-throughput testing system for infections.

A Vision for the Future

At the Medical Faculty, her future work will further strengthen the ties between the two research foci “Immunity and Infections” and “Genetics and Epidemiology”. As she steps into her role as professor, Kerstin Ludwig envisions expanding her research to address the contribution of genetic profiles to immune-mediated traits, and to integrate human genetic data into many research applications. 

"I am honored to continue my journey at the University of Bonn and within the ImmunoSensation community. Bonn offers a unique environment that will allow integrating genomic information into a variety of research projects. Also, the highly collaborative and complementary nature of the ImmunoSensation groups enables to push the boundaries of translating genetic findings into an improved understanding of molecular pathophysiologies," she shared.

The appointment of Kerstin Ludwig strengthens the Cluster’s expertise in understanding the role of the immune system in health and disease. Her work contributes to the overarching mission of ImmunoSensation2 by exploring how genetic and environmental factors interact with immune pathways to influence immune and infectious diseases.

We congratulate Kerstin Ludwig on her well-deserved professorship and look forward to the groundbreaking contributions she will continue to bring to the scientific community in Bonn.

 

Contact 

Prof. Dr. Kerstin Ludwig

Institute of Human Genetics, University Hospital Bonn

E-Mail: kerstin.ludwig@uni-bonn.de

Kerstin Ludwig W2 professorship
Prof. Dr. Kerstin Ludwig
© Bernadett Yehdou

Related news

Zwei Personen: Links Prof. Pröpstl und rechts Prof. Boztug

News categories: Honors & Funding

University of Bonn and University Hospital Bonn strengthen early-career clinical scientists

The Faculty of Medicine at the University of Bonn and the University Hospital Bonn (UKB) are jointly launching the EKFS doctoral program IMMUNE PILOT, which introduces medical students to clinical-scientific research at an early stage. The structured program is positioned at the interface of immunology, neuroscience, and genetics and is aimed at students with a strong interest in research who aspire to pursue a career as clinician scientists. The program is funded by the Else Kröner-Fresenius Foundation (EKFS).
View entry
PrepAIred

News categories: Honors & Funding

Precise active ingredients against pancreatic cancer

Pancreatic cancer remains one of the deadliest forms of cancer. At the German Cancer Congress 2026, German Cancer Aid is now presenting three large-scale projects that it is funding as part of its “German Alliance for Pancreatic Cancer” funding priority. In the funded project PrepAIred, Bonn researchers , in cooperation with the University of North Carolina (USA), want to use AI-based protein design to specifically combat pancreatic cancer. German Cancer Aid is funding the project with a total of 1.99 million euros over a period of four years.
View entry
Gruppenbild Preistrager Lisec Artz Preisverleihung

News categories: Honors & Funding

Niklas Klümper and Varun Venkataramani receive Lisec-Artz Prize

Dr. Varun Venkataramani of the Faculty of Medicine at Heidelberg University and ImmunoSensation² member Dr. Niklas Klümper of the University Hospital Bonn have been awarded the Lisec Artz Prize for their outstanding cancer research. The University of Bonn Foundation and the University of Bonn Faculty of Medicine presented the awards to the two researchers on Tuesday, November 18, 2025 at the University Hospital Bonn (UKB) as part of the Cluster Science Days event held by the ImmunoSensation² Cluster of Excellence. The prize is worth a total of 15,000 euros.
View entry

Back to the news overview